Table 3.
Fully adjusted associations between patient characteristics and resolution of any symptoms and specific symptoms 6 months post-ablation among patients with the symptom pre-ablation, n = 651, odds ratios (ORs), and 95% confidence intervals (95% CIs)
| Characteristic | Any symptoms | Anxiety | Chest pain | Dizziness | Dyspnoea | Oedema |
|---|---|---|---|---|---|---|
| Age (ref: under 65, n = 255) | 1.16 (0.63–2.09) | 0.95 (0.61–1.47) | 0.96 (0.63–1.46) | 1.16 (0.78–1.75) | 0.86 (0.60–1.25) | 1.00 (0.69–1.47) |
| Gender (ref: Male, n = 408) | 0.78 (0.41–1.42) | 0.46 (0.31–0.69) | 0.71 (0.48–1.06) | 0.65 (0.45–0.96) | 0.82 (0.57–1.17) | 1.00 (0.69–1.45) |
| Race (ref: White, n = 393) | ||||||
| Asian (n = 34) | 0.92 (0.21–2.90) | 4.70 (1.36–29.60) | 0.75 (0.33–1.87) | 0.65 (0.30–1.55) | 0.87 (0.41–1.91) | 0.52 (0.23–1.16) |
| Black/African American (n = 40) | 0.71 (0.16–2.24) | 1.05 (0.49–2.41) | 0.74 (0.36–1.61) | 0.60 (0.30–1.24) | 1.10 (0.53–2.33) | 0.48 (0.23–1.00) |
| Ethnicity (ref: not Hispanic/Latino, n = 616) | 1.48 (0.32–5.16) | 0.42 (0.19–1.00) | 0.47 (0.21–1.12) | 0.71 (0.31–1.75) | 0.55 (0.24–1.24) | 0.58 (0.24–1.37) |
| Neighbourhood SDIa (ref: not deprived, n = 477) | 1.10 (0.56–2.07) | 1.07 (0.68–1.75) | 1.73 (1.06–2.92) | 1.46 (0.93–2.37) | 1.09 (0.73–1.65) | 1.02 (0.68–1.54) |
| Antiarrhythmic rxb (ref: no rx, n = 503) | 1.65 (0.89–3.00) | 0.94 (0.59–1.52) | 1.15 (0.73–1.86) | 0.61 (0.41–0.93) | 0.87 (0.59–1.30) | 1.17 (0.78–1.76) |
| Rate control rxb (ref: no rx, n = 347) | 1.13 (0.64–1.98) | 0.68 (0.45–1.02) | 0.75 (0.51–1.12) | 0.79 (0.54–1.16) | 0.91 (0.64–1.29) | 0.80 (0.56–1.13) |
| Alcohol history (ref: no history, n = 224) | 0.91 (0.51–1.67) | 1.07 (0.70–1.62) | 0.91 (0.61–1.37) | 0.80 (0.54–1.18) | 1.28 (0.89–1.83) | 1.19 (0.83–1.71) |
| Smoking history (ref: no history, n = 407) | 1.06 (0.58–1.89) | 0.74 (0.49–1.13) | 0.88 (0.58–1.34) | 0.72 (0.48–1.07) | 0.71 (0.50–1.02) | 0.60 (0.42–0.87) |
| Heart failure (ref: no heart failure, n = 251) | 0.96 (0.52–1.76) | 0.68 (0.44–1.04) | 0.51 (0.33–0.78) | 0.76 (0.51–1.13) | 0.41 (0.28–0.59) | 0.33 (0.23–0.48) |
| Fatigue | Malaise | Palpitations | Syncope | Weakness | ||
| Age (ref: under 65, n = 255) | 0.94 (0.63–1.41) | 0.94 (0.32–2.90) | 0.58 (0.40–0.85) | 0.75 (0.47–1.22) | 0.70 (0.37–1.34) | |
| Gender (ref: Male, n = 408) | 0.94 (0.63–1.39) | 2.42 (0.73–11.10) | 0.42 (0.29–0.61) | 0.65 (0.41–1.03) | 0.55 (0.30–1.00) | |
| Race (ref: White, n = 393) | ||||||
| Asian (n = 34) | 1.16 (0.50–3.03) | 0.43 (0.07–8.34) | 1.12 (0.51–2.61) | 0.98 (0.36–3.46) | 1.59 (0.43–10.30) | |
| Black/African American (n = 40) | 0.94 (0.46–1.98) | 0.17 (0.04–0.91) | 0.72 (0.35–1.51) | 0.59 (0.27–1.40) | 0.73 (0.28–2.15) | |
| Ethnicity (ref: not Hispanic/Latino, n = 616) | 1.82 (0.70–5.71) | NA | 0.89 (0.39–2.14) | 1.17 (0.42–4.20) | NA | |
| Neighbourhood SDIa (ref: not deprived, n = 477) | 1.23 (0.79, 1.97) | 1.13 (0.35, 5.05) | 1.13 (0.74, 1.75) | 0.89 (0.54, 1.51) | 1.23 (0.60, 2.80) | |
| Antiarrhythmic rxb (ref: no rx, n = 503) | 0.66 (0.44–1.02) | 0.87 (0.29–3.23) | 0.92 (0.61–1.42) | 0.55 (0.34–0.91) | 0.59 (0.32–1.13) | |
| Rate control rxb (ref: no rx, n = 347) | 1.05 (0.72–1.53) | 0.50 (0.17–1.41) | 0.73 (0.50–1.04) | 0.64 (0.41–1.01) | 0.62 (0.33–1.14) | |
| Alcohol history (ref: no history, n = 224) | 1.19 (0.81–1.76) | 0.72 (0.22–2.11) | 1.41 (0.97–2.05) | 0.63 (0.38–1.02) | 1.87 (1.01–3.46) | |
| Smoking history (ref: no history, n = 407) | 0.84 (0.56–1.26) | 0.46 (0.16–1.30) | 1.05 (0.71–1.55) | 1.03 (0.64–1.68) | 0.59 (0.32–1.11) | |
| Heart failure (ref: no heart failure, n = 251) | 0.46 (0.30–0.69) | 1.18 (0.39–3.66) | 1.90 (1.30–2.81) | 0.84 (0.51–1.35) | 0.53 (0.27–1.02) |
Bold values indicate statistical significance at P < 0.05.
aSocial deprivation index (SDI) measured at the census tract level. SDI <90 is considered not deprived.
bRx = active prescription at 6 months post-ablation, per electronic health records.